Clinical Trial Update: Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 safety evaluation of Rexin-G gene transfer in advanced pancreatic cancer; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Rexin-G

Snippet

Sponsor: Epeius Biotechnologies | Conditions: Pancreatic Cancer | Phase 1 | Status: TERMINATED